简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
HOME
·
Dizal
Dizal files for HKEX listing with Goldman Sachs and Huatai International as joint sponsors; sunvozertinib licensed globally to AstraZeneca for USD 600 million upfront
Tags：
Dizal
IPO
file a listing application
2026-08-28
DIZAL PHARMACEUTICAL CO., LTD. HKEX Listing Application Lapsed; Flagship Asset ZEGFROVY® Is the World’s Only Approved Small-molecule Targeted Therapy for EGFR Exon20ins-mutated Lung Cancer
Tags：
Dizal
IPO
IPO application lapsed
2026-07-23
Featured News
ETF
CSOP NASDAQ-100 Index Daily (-2x) Inverse Product (07568.HK) Gains 2.12% Intraday, AUM Hits HK$1.365 Billion
ETF
Csop Nikkei 225 Daily (-2x) Inverse Product (07515.HK) Rises 2.56% Intraday at HK$15.250
Research
Shanghai-Shenzhen Stock Connect ETFs Daily Report: Pharmaceutical & Biotechnology Themes Strengthen Broadly; Military and Communication Retreat from Highs - 20260914
Research
Weekly Shanghai-Shenzhen Stock Connect ETFs Average Return Statistics (By Fund Manager) (Second Week of September 2026)
Tech
Autonomous Driving Concept Stocks Watch | Haikou Jiangdong New Area Autonomous Driving Pilot Approved, BIDU-W (09888.HK) Traded Stronger in Afternoon Session
Research
Weekly Shanghai-Shenzhen Stock Connect ETFs Return Statistics (Second Week of September 2026)
Research
HK Connect Weekly: Hang Seng TECH Index Down 5.56% for the Week; Stock Connect List Adjustment Implemented; BIDU-W Officially Joins Stock Connect - 20260911
Overseas
Going Global Weekly: Pharma Licensing and Overseas Registrations Land in Cluster, Manufacturing Capacity Expansion in Southeast Asia Accelerates-20260911
Finance
SITOY GROUP (01023.HK): Profit Warning, Full-year Loss Attributable to Owners Expected to Narrow to HKD 110,000,000 to HKD 130,000,000
Finance
DIAGENS-B (02526.HK): Signs Three-Year Cooperation Framework Agreement with Anzhen'er on Provincial Medical Imaging AI Platform
Scan QR Code
Download App
